Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers

Journal of Virology

Volumn 85, Issue 6, 2011, Pages 3015-3019

  Vigneault, Francois ^a,b   Woods, Matthew ^b   Buzon, Maria J ^c   Li, Chun ^b   Pereyra, Florencia ^b   Crosby, Seth D ^d   Rychert, Jennifer ^b   Church, George ^a   Martinez Picado, Javier ^c,e   Rosenberg, Eric S ^b   Telenti, Amalio ^f   Yu, Xu G ^b   Lichterfeld, Mathias ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FOCAL ADHESION KINASE; HLA ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE;

ADULT; ALLELE; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION PROFILING; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79952408305     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01846-10     Document Type: Article

References (33)

1. Baker, B. M., B. L. Block, A. C. Rothchild, and B. D. Walker. 2009. Elite control of HIV infection: implications for vaccine design. Expert Opin. Biol. Ther. 9:55-69.
2. Blankson, J. N. 2010. Control of HIV-1 replication in elite suppressors. Discov. Med. 9:261-266.
3. Blankson, J. N., et al. 2007. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J. Virol. 81:2508-2518.
4. Bosinger, S. E., et al. 2009. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J. Clin. Invest. 119:3556-3572.
5. Brass, A. L., et al. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319:921-926. (Pubitemid 351263756)
6. Dean, M., et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multi-center Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856-1862. (Pubitemid 26322495)
7. Doria-Rose, N. A., et al. 2010. Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables. J. Virol. 84:1631-1636.
8. Fellay, J., et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317:944-947. (Pubitemid 47301321)
9. Hazenberg, M. D., et al. 2000. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95:249-255.
10. Hsue, P. Y., et al. 2009. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 23:1059-1067.
11. Hunt, P. W., et al. 2008. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197:126-133.
12. Kanehisa, M., S. Goto, M. Furumichi, M. Tanabe, and M. Hirakawa. 2010. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38:D355-D360.
13. Kaslow, R. A., et al. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-411.
14. Lamine, A., et al. 2007. Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study). AIDS 21:1043-1045. (Pubitemid 46684337)
15. Li, L. 2010. Dimension reduction for high-dimensional data. Methods Mol. Biol. 620:417-434.
16. Lichterfeld, M., et al. 2004. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J. Exp. Med. 200:701-712.
17. Lichterfeld, M., et al. 2007. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J. Exp. Med. 204:2813-2824.
18. Lohse, N., et al. 2007. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann. Intern. Med. 146:87-95.
19. Migueles, S. A., et al. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068.
20. Migueles, S. A., et al. 2008. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29:1009-1021.
21. Mootha, V. K., et al. 2003. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:267-273.
22. Newell, K. A., et al. 2010. Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120:1836-1847.
23. Palmer, S., et al. 2008. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc. Natl. Acad. Sci. U. S. A. 105:3879-3884.
24. Pereyra, F., et al. 2009. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J. Infect. Dis. 200:984-990.
25. Richman, D. D., et al. 2009. The challenge of finding a cure for HIV infection. Science 323:1304-1307.
26. Rotger, M., et al. 2010. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog. 6:e1000781.
27. Saez-Cirion, A., et al. 2007. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. U. S. A. 104:6776-6781.
28. Saez-Cirion, A., G. Pancino, M. Sinet, A. Venet, and O. Lambotte. 2007. HIV controllers: how do they tame the virus? Trends Immunol. 28:532-540.
29. Sedaghat, A. R., et al. 2009. T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors. Clin. Infect. Dis. 49:1763-1766.
30. Smyth, G. K. 2005. Limma: linear models for microarray data, p. 397-420. In R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, and W. Huber (ed.), Bioinformatics and computational biology solutions using R and Bioconductor. Springer, New York, NY.
31. Subramanian, A., et al. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-15550.
32. Telenti, A., and D. B. Goldstein. 2006. Genomics meets HIV-1. Nat. Rev. Microbiol. 4:865-873.
33. Trono, D., et al. 2010. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science 329:174-180.